NASHVILLE, Tenn. — Alcon’s U.S. pharmaceutical division shared its focus on glaucoma and dry eye with attendees at Optometry’s Meeting.
“We are continuing to look for innovation around dry eye disease and glaucoma,” Lisa Praeger, general manager for U.S. pharmaceutical and dry eye at Alcon, said in this Healio video.
Products highlighted at the meeting include Rhopressa (netarsudil ophthalmic solution 0.02%), Rocklatan (netarsudil 0.02%/latanoprost 0.005% ophthalmic solution), Simbrinza (brinzolamide 1%/brimonidine tartrate 0.2% ophthalmic suspension) and Eysuvis